Tech Company Financing Transactions
Transposon Therapeutics Funding Round
Transposon Therapeutics, based in San Diego, secured investment from Alzheimer's Drug Discovery Foundation.
Transaction Overview
Company Name
Announced On
7/9/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4660 La Jolla Village Drive 100 and 200
San Diego, CA 92122
USA
San Diego, CA 92122
USA
Phone
Website
Email Address
Overview
Our mission is to develop innovative treatments for LINE-1 associated neurodegenerative disease. Almost half of our genome is occupied by virus-like elements called "retrotransposons", which have been introduced into our genome over millions of years. Retrotransposons are mobile DNA elements that use a "reverse transcriptase" enzyme to self-replicate and proliferate. Since these activities can be damaging to our cells, our bodies maintain strict control over retrotransposon expression.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dennis Podlesak
Browse more venture capital transactions:
Prev: 7/9/2025: Candid Hospitality venture capital transaction
Next: 7/9/2025: Million Victories venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs